Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 10815219
2,4-diaminoquinazoline derivatives for inhibiting endoplasmic reticulum (ER) stress
granted -
US 10815250
AhR modulators
granted -
US 10815276
Cell penetrating peptides and methods of making and using thereof
granted -
US 10815271
Structure-based peptide inhibitors of alpha-synuclein aggregation
granted -
US 10815295
Broadly neutralizing HIV-1 antibodies that bind to the CD4-binding site of the envelope protein
granted -
US 10815266
β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment
granted -
US 10815285
Recombinant adeno-associated virus-mediated expression of fractalkine for treatment of neuroinflammatory and neurodegenerative diseases
granted -
US 10815463
Messenger UNA molecules and uses thereof
granted -
US 10815455
Salmonella-based vectors for cancer immunotherapy targeting Wilms' tumor gene WT1
granted -
US 10815480
Modulation of alpha synuclein expression
granted -
US 10815483
Compositions for modulating C9ORF72 expression
granted -
US 10815485
RNA interference in skin indications
granted -
US 10815484
Compositions and methods for treating cancer
granted -
US 10815488
Chimeric antigen receptors targeting B-cell maturation antigen
granted -
US 10806700
Oral dosage forms for delivery of therapeutic agents
granted -
US 10808230
Selection methods for genetically-modified T cells
granted -
US 10808225
Use of PDL1 expressing cells to convert T cells into regulatory T cells
granted -
US 10808011
Recombinant HIV-1 envelope proteins and their use
granted -
US 10808246
Oligonucleotide-ligand conjugates and process for their preparation
granted -
US 10808004
Triterpene-glycoside as sweetener or sweetener enhancer
granted -
US 10808020
Nuclease-mediated regulation of gene expression
granted -
US 10807951
mTORC1 modulators
granted -
US 10806807
TCO conjugates and methods for delivery of therapeutic agents
granted -
US 10806794
Protease inhibitors having enhanced features
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.